Related references
Note: Only part of the references are listed.Challenging the equipotency calculation for transdermal buprenorphine: four case studies
R. Likar et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Buprenorphine ameliorates the effect of surgery on hypothalamus-pituitary-adrenal axis, natural killer cell activity and metastatic colonization in rats in comparison with morphine or fentanyl treatment
Silvia Franchi et al.
BRAIN BEHAVIOR AND IMMUNITY (2007)
Long-term use of controlled-release oxycodone for noncancer pain: Results of a 3-year registry study
Russell K. Portenoy et al.
CLINICAL JOURNAL OF PAIN (2007)
Is there a ceiling effect of transdermal buprenorphine? Preliminary data in cancer patients
Sebastiano Mercadante et al.
SUPPORTIVE CARE IN CANCER (2007)
Systematic review: Opioid treatment for chronic back pain: Prevalence, efficacy, and association with addiction
Bridget A. Martell et al.
ANNALS OF INTERNAL MEDICINE (2007)
Buprenorphine in long-term control of chronic pain in cancer patients
Maria Caterina Pace et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2007)
Effects of intermittent hemodialysis on buprenorphine and norbuprenorphine plasma concentrations in chronic pain patients treated with transdermal buprenorphine
Joerg Filitz et al.
EUROPEAN JOURNAL OF PAIN (2006)
Transdermal buprenorphine in pain management - experiences from clinical practice: five case studies
F. Louis
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2006)
Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine
Sebastiano Mercadante et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2006)
Fracture risk associated with the use of morphine and opiates
P. Vestergaard et al.
JOURNAL OF INTERNAL MEDICINE (2006)
Long-term management of chronic pain with transdermal buprenorphine: A multicenter, open-label, follow-up study in patients from three short-term clinical trials
Rudolf Likar et al.
CLINICAL THERAPEUTICS (2006)
Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment
H Breivik et al.
EUROPEAN JOURNAL OF PAIN (2006)
Buprenorphine induces ceiling in respiratory depression but not in analgesia
A Dahan et al.
BRITISH JOURNAL OF ANAESTHESIA (2006)
Reversibility of opioid receptor occupancy of buprenorphine in vivo
W Englberger et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model
W Koppert et al.
PAIN (2005)
Interaction of μ-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice
B Kögel et al.
EUROPEAN JOURNAL OF PAIN (2005)
Transdermal buprenorphine in clinical practice - a post-marketing surveillance study in 13179 patients
N Griessinger et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine and fentanyl in rats: Role of receptor equilibration kinetics
A Yassen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats
A Dahan et al.
BRITISH JOURNAL OF ANAESTHESIA (2005)
Randomized clinical trial to compare the effects of methadone and buprenorphine on the immune system in drug abusers
S Neri et al.
PSYCHOPHARMACOLOGY (2005)
Effectiveness and tolerability of the buprenorphine transdermal system in patients with moderate to severe chronic pain:: A multicenter, open-label, uncontrolled, prospective, observational clinical study
C Muriel et al.
CLINICAL THERAPEUTICS (2005)
Transdermal buprenorphine for treating nociceptive and neuropathic pain: Four case studies
R Likar et al.
ANESTHESIA AND ANALGESIA (2005)
Buprenorphine: Considerations for pain management
RE Johnson et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2005)
Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: Results of a retrospective cohort study
R Sittl et al.
CLINICAL THERAPEUTICS (2005)
Broad analgesic profile of buprenorphine in rodent models of acute and chronic pain
T Christoph et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Treatment of cancer-related pain with transdermal buprenorphine: a report of three cases
P Schriek
SUPPORTIVE CARE IN CANCER (2004)
Chronic fentanyl or buprenorphine infusion in the mouse: similar analgesic profile but different effects on immune responses
C Martucci et al.
PAIN (2004)
Transdermal buprenorphine in the treatment of chronic pain: Results of a Phase III, multicenter, randomized, double-blind, placebo-controlled study
J Sorge et al.
CLINICAL THERAPEUTICS (2004)
Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000
MA Caudill-Slosberg et al.
PAIN (2004)
Interaction of buprenorphine and its metabolite norbuprenorphine with cytochromes P450 in vitro
WJ Zhang et al.
DRUG METABOLISM AND DISPOSITION (2003)
Safety and health policy considerations related to the use of buprenorphine/naloxone as an office-based treatment for opiate dependence
TP Bridge et al.
DRUG AND ALCOHOL DEPENDENCE (2003)
Pharmacokinetics of the combination tablet of buprenorphine and naloxone
CN Chiang et al.
DRUG AND ALCOHOL DEPENDENCE (2003)
The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic
SL Walsh et al.
DRUG AND ALCOHOL DEPENDENCE (2003)
Efficacy and tolerability of a new opioid analgesic formulation, buprenorphine transdermal therapeutic system (TDS), in the treatment of patients with chronic pain. A randomised, double-blind, placebo-controlled study
K Bohme et al.
PAIN CLINIC (2003)
Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: A multicenter, randomized, double-blind, placebo-controlled trial
R Sittl et al.
CLINICAL THERAPEUTICS (2003)
Inhibition of human drug metabolizing cytochrome P450 by buprenorphine
K Umehara et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2002)
Intravenous buprenorphine self-administration by detoxified heroin abusers
SD Comer et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Deaths involving buprenorphine: a compendium of French cases
P Kintz
FORENSIC SCIENCE INTERNATIONAL (2001)
A new model of electrically evoked pain and hyperalgesia in human skin -: The effects of intravenous alfentanil, S(+)-ketamine, and lidocaine
W Koppert et al.
ANESTHESIOLOGY (2001)
Transdermal fentanyl for the management of cancer pain: a survey of 1005 patients
L Radbruch et al.
PALLIATIVE MEDICINE (2001)
Effect of peripheral morphine in a human model of acute inflammatory pain
J Lilleso et al.
BRITISH JOURNAL OF ANAESTHESIA (2000)
Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon periaqueductal gray
R Gomez-Flores et al.
IMMUNOPHARMACOLOGY (2000)
Clinical pharmacokinetics of transdermal opioids - Focus on transdermal fentanyl
S Grond et al.
CLINICAL PHARMACOKINETICS (2000)
Share Paper
